Company profile: Vivos
1.1 - Company Overview
Company description
- Provider of breathing wellness-focused medical R&D, offering FDA-cleared Class II mmRNA (for jaw repositioning) and mRNA appliances for treating adult mild-to-moderate sleep apnea/snoring; FDA-registered Class I DNA palatal expansion and Guide Series tooth-positioning appliances; the SleepImage System to measure sleep quality; and medical billing for OAT, sleep apnea, TMJ, and DME.
Products and services
- Vivos mmRNA: An FDA-cleared Class II appliance engineered for jaw repositioning to treat mild-to-moderate sleep apnea and snoring in adults.
- Vivos mRNA: An FDA-cleared Class II appliance from Vivos Therapeutics for treating mild-to-moderate sleep apnea and snoring in adults.
- Medical Billing Services: Comprehensive billing services for oral appliance therapy, sleep apnea, TMJ, and DME, including verification of benefits and pre-authorization.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Vivos
Benezon
HQ: United States
Website
- Description: Provider of personalized service to help plan members navigate the complexities of the healthcare system, with a mobile app placing advocacy and telemedicine in the palm of your hand.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Benezon company profile →
Parla
HQ: United Kingdom
Website
- Description: Provider of digital reproductive health solutions, offering at-home fertility blood tests and expert-led masterclasses and courses. Programs cover endometriosis, PCOS, menopause, baby loss, and fertility/conception, delivering accessible educational information and proactive support to women.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Parla company profile →
Kalmeda
HQ: Germany
Website
- Description: Provider of solutions for tinnitus patients, focused on creating an effective therapy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Kalmeda company profile →
Uplift
HQ: United States
Website
- Description: Provider of an interactive digital program for depression based on Cognitive Behavioral Therapy, featuring 12 weekly 40-minute sessions to build coping skills and daily tools to apply them. Additional features include a PHQ-9-based depression test, a mood journal, and a strengths portfolio to identify and leverage personal strengths.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Uplift company profile →
Hume AI
HQ: United States
Website
- Description: Provider of AI with emotional intelligence, offering: Empathic Voice Interface (EVI) that interprets emotional expressions and generates empathic responses, integrating transcription, language modeling, and text-to-speech; Expression Measurement API for vocal and facial cues from audio, video, and images; Custom Model API for outcome prediction via transfer learning; and HumE-1, a human-rated LLM evaluation framework.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Hume AI company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Vivos
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Vivos
2.2 - Growth funds investing in similar companies to Vivos
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Vivos
4.2 - Public trading comparable groups for Vivos
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →